HLS Therapeutics to Host Q4 and Fiscal 2020 Financial Results Conference Call

About this update from Hls Therapeutics, Inc.

[{"type":"text","content":"\n \n \n \n HLS Therapeutics to Host Q4 and Fiscal 2020 Financial Results Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n TORONTO\n \n ,\n \n March 4, 2021\n \n /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), announces that it will release its Q4 and fiscal 2020 financial results by press release at\n \n 6:30 a.m. EST on Thursday\n \n , March 18, 2021. The Company will hold a conference call that same day at\n \n 8:30 a.m. EST\n \n to discuss its results. The call will be hosted by Mr.\n \n Gilbert Godin\n \n , Chief Executive Officer and Mr.\n \n Tim Hendrickson\n \n , Chief Financial Officer.\n \n Slides to accompany management's prepared remarks will be available to view via the webcast\n \n .\n \n \n \n \n \n \n \n CONFERENCE ID:\n \n \n \n \n \n \n 39965985\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n DATE:\n \n \n \n \n \n \n Thursday, March 18, 2021\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n TIME:\n \n \n \n \n \n \n 8:30 a.m. EST\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n DIAL-IN NUMBER:\n \n \n \n \n \n \n 1-888-664-6392 or 416-764-8659\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n WEBCAST LINK:\n \n \n \n \n \n \n \n https://produceredition.webcasts.com/starthere.jsp?ei=1425876&tp_key=3150153748\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n TAPED REPLAY:\n \n \n \n \n \n \n 1-888-390-0541 or 416-764-8677\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n REPLAY CODE:\n \n \n \n \n \n \n 965985\n \n \n \n \n \n \n \n The ta...

More updates from Hls Therapeutics, Inc.